Generic Launches – Winter 2024

Start
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications….
By: Robins Kaplan LLP
Previous Story

AultCare Announces Data Breach Affecting Employer-Sponsored Health Plan Participants

Next Story

Streamlining eDiscovery: The Case for Supervised Collections and Custodial Interviews